New designer drugs N‐(1‐phenylcyclohexyl)‐2‐ethoxyethanamine (PCEEA) and N‐(1‐phenylcyclohexyl)‐2‐methoxyethanamine (PCMEA): Studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques
Authors:
- 29 October 2007
- journal article
- research article
- Published by Wiley in Journal of Mass Spectrometry
- Vol. 43 (3) , 305-316
Abstract
Studies are described on the metabolism and the toxicological detection of the phencyclidine‐derived designer drugs N‐(1‐phenylcyclohexyl)‐2‐ethoxyethanamine (PCEEA) and N‐(1‐phenylcyclohexyl)‐2‐methoxyethanamine (PCMEA) in rat urine using gas chromatographic/mass spectrometric (GC/MS) techniques. The identified metabolites indicated that PCEEA and PCMEA were transformed to the same metabolites by N‐dealkylation and O‐dealkylation partially followed by oxidation of the resulting alcohol to the respective carboxylic acid and hydroxylation of the cyclohexyl ring at different positions and combinations of those. Finally, aromatic hydroxylation of the O‐dealkylated metabolites was partially followed by hydroxylation of the cyclohexyl ring at different positions. All metabolites were partially excreted in conjugated form. The authors' systematic toxicological analysis (STA) procedure using full‐scan GC/MS after acid hydrolysis, liquid–liquid extraction and microwave‐assisted acetylation allowed the detection of an intake of a common drug users' dose both of PCEEA and PCMEA in rat urine. Assuming similar metabolism in humans, the STA should be suitable for proof of an intake of PCEEA and PCMEA in human urine, although their differentiation is not possible due to common metabolites. Copyright © 2007 John Wiley & Sons, Ltd.Keywords
This publication has 19 references indexed in Scilit:
- Hyphenated mass spectrometric techniques—indispensable tools in clinical and forensic toxicology and in doping controlJournal of Mass Spectrometry, 2006
- New designer drug N‐(1‐phenylcyclohexyl)‐3‐ethoxypropanamine (PCEPA): Studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniquesJournal of Mass Spectrometry, 2006
- Designer drugs 2,5‐dimethoxy‐4‐bromo‐amphetamine (DOB) and 2,5‐dimethoxy‐4‐bromo‐methamphetamine (MDOB): studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniquesJournal of Mass Spectrometry, 2006
- Studies on the metabolism and toxicological detection of the designer drug 4-methylthioamphetamine (4-MTA) in human urine using gas chromatography–mass spectrometryJournal of Chromatography B, 2005
- New designer drug 2,5‐dimethoxy‐4‐ethylthio‐β‐phenethylamine (2C‐T‐2): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometryJournal of Mass Spectrometry, 2005
- New designer drug, 2,5‐dimethoxy‐4‐propylthio‐β‐phenethylamine (2C‐T‐7): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometryJournal of Mass Spectrometry, 2005
- New designer drug 1‐(3,4‐methylenedioxybenzyl) piperazine (MDBP): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometryJournal of Mass Spectrometry, 2004
- Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping controlClinical Chemistry and Laboratory Medicine (CCLM), 2004
- Synthesis and anticonvulsant activity of 1-phenylcyclohexylamine analogsJournal of Medicinal Chemistry, 1990
- Phenylcyclohexylamine: Effect of a metabolite of phencyclidine on the efflux of dopamine in the ratNeuropharmacology, 1986